Zydus Lifesciences Share Price: Board ne approve kiya ₹1,100 Cr ka Buyback, Investors ki hogi Maza?

OTHER
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Zydus Lifesciences Share Price: Board ne approve kiya ₹1,100 Cr ka Buyback, Investors ki hogi Maza?
Overview

Badi khabar Zydus Lifesciences se! Company ke board ne ₹1,100 crore ka share buyback approve kar diya hai. Matlab company ₹1,150 per share dekar logo se shares wapas kharidegi. Yeh investors ke liye ek acchi baat hai jo company ki financial health dikhata hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

So, Zydus Lifesciences ke management ne finally ek bada plan approve kiya hai – ₹1,100 Crore ka share buyback! Iske through company apne investors se shares wapas khareedegi.

Kya hai offer?

Company ₹1,150 per share ke hisaab se shares buy karegi. Total 95.65 Lakh Shares kharidne ka plan hai, jo company ke total paid-up capital ka 0.95% banta hai. Yeh sab 'tender offer' route se hoga. Iska matlab hai ki jo shareholders apne shares company ko bechna chahte hain, woh is offer mein apply kar sakte hain.

Investors ka kya fayda?

Aise buybacks investors ko kafi pasand aate hain. Jab company apne shares wapas kharidti hai, toh market mein total shares kam ho jaate hain. Isse har ek share ki value badhti hai aur company ka profit per share (EPS) bhi increase hota hai. Yeh move dikhata hai ki Zydus ke paas surplus cash hai aur woh apne future ko lekar confident hai. Unhone FY24 mein ₹17,706 Crore ki consolidated revenue aur ₹2,110 Crore ka Profit After Tax (PAT) report kiya tha, jisse unka EPS ₹20.82 tha.

Aur kya details hain?

Yeh ₹1,100 Crore sirf share buyback ke liye hain. Iske alawa brokerage fees, taxes, SEBI fees wagera ka kharcha alag hoga. Jo shareholders buyback mein participate karna chahte hain, unke liye record date 29 May, 2026 set ki gayi hai.

Pharma sector mein Zydus kaafi bada player hai, jahan Sun Pharma, Dr. Reddy's, aur Cipla jaise competitors bhi hain. Lekin yeh buyback move company ke liye ek positive signal hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.